Panasonic's Continuous Sustainable Seafood Efforts in Its Corporate Cafeterias Win "Japan Sustainable Seafood Award" Champion
28.11.2019 07:14:00 EET | Business Wire | Press release
On November 7, 2019, Panasonic's efforts to transform consumer behavior and contribute to the achievement of SDGs (*1) by promoting sustainable seafood in its corporate cafeterias won the Initiative Award Champion at the inaugural "Japan Sustainable Seafood Award" during the Tokyo Sustainable Seafood Symposium 2019.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191127005693/en/
Sustainable Seafood Award Ceremony (Photo: Business Wire)
[Video] Protect Marine Life with Corporate Cafeterias - Sustainable Seafood Initiatives [Panasonic]
https://youtu.be/lnPtiBO12ok
The Japan Sustainable Seafood Award is given to people, organizations, and projects that contribute to the promotion of sustainable seafood and enhance the sustainability of the fisheries industry in Japan, and is comprised of the Initiative and Collaboration Award categories. Panasonic's project was selected as one of the finalists for the Initiative Award and ultimately awarded as the Champion.
From March 2018, Panasonic has been serving MSC, ASC certified (*2) sustainable seafood in its cafeterias. MSC and ASC certifications are the only 2 certifications recognized by WWF, and Panasonic became the first company to continuously serve such sustainable seafood in its corporate cafeterias. As of November 20, 2019, sustainable seafood has been adopted at 27 cafeterias, and by the end of FY2020, Panasonic is aiming to serve sustainable seafood in approximately 100 corporate cafeterias in Japan.
Panasonic became the Champion for taking the initiative to adopt sustainable seafood in its corporate cafeterias and for promoting CoC (*3) certification among the food service industry. Its efforts were also highly recognized because of the significant social impact it can have through its numerous employees and for the know-how it has provided to other companies.
Through these efforts, Panasonic will continue to contribute to achieving SDGs by enhancing awareness for sustainable seafood and by changing consumer behavior. More specifically, through its activities in corporate cafeterias, Panasonic will communicate to its employees the critical situation of fishery resources, and augment employee awareness for MSC and ASC certification, so that they will change their consumer behavior and begin choosing sustainable seafood even outside their workplace.
*1 SDGs refer to the 2030 Agenda for Sustainable Development comprised of 17 Sustainability Development Goals unanimously adopted at the United Nations in 2015. This initiative specifically addresses Goal 14: Conserve and sustainably use the oceans, seas and marine resources.
*2 MSC (Marine Stewardship Council) certifies sustainable and appropriately managed fisheries, while ASC (Aquaculture Stewardship Council) certifies responsible aquaculture practices that minimize harm to the environment and society. In both cases, products and suppliers are audited against stringent standards by a third-party certifying organization.
*3 Abbreviation for Chain of Custody, which refers to processing and distribution control. It is a system that ensures the traceability of products by following the route they have taken in their distribution and processing in order to prevent contamination of uncertified seafood into certified seafood.
About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th anniversary in 2018, has expanded globally and now operates 582 subsidiaries and 87 associated companies worldwide, recording consolidated net sales of 8.003 trillion yen for the year ended March 31, 2019. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global.
Source: https://news.panasonic.com/global/topics/2019/73623.html
Related Links
Environment: Biodiversity Conservation | Panasonic
https://www.panasonic.com/global/corporate/sustainability/eco/biodiversity.html
Sustainability | Panasonic
https://www.panasonic.com/global/corporate/sustainability.html
Sustainability Data Book 2019 | Panasonic
https://www.panasonic.com/global/corporate/sustainability/downloads.html
[Feature Story] Conserve Marine Environment through Its Corporate Cafeterias - Panasonic's Challenge to Propagating Sustainable Seafood (Aug 02, 2019)
https://news.panasonic.com/global/stories/2019/70462.html
[Video] Protect Marine Life with Corporate Cafeterias - Sustainable Seafood Initiatives [Panasonic]
https://youtu.be/lnPtiBO12ok
[Video Review] Protect Marine Life with Corporate Cafeterias - Sustainable Seafood Initiatives (Jul 04, 2019)
https://news.panasonic.com/global/stories/2019/69670.html
Creating a Better World Through "Sustainable Development Goals" (Nov 01, 2018)
https://news.panasonic.com/global/stories/2018/62660.html
Sustainable Development Knowledge Platform - United Nations
https://sustainabledevelopment.un.org/
Japan Sustainable Seafood Award - Tokyo Sustainable Seafood Symposium
https://sustainableseafoodnow.com/2019/en/award/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191127005693/en/
Contact information
Panasonic Corporation
Global Communications Department
Global PR Office
Click here to go to Media Contact form
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom